XXI International Men's Health Congress

Riviera Biotech participated in the XXI Men's Health Congress, which was held from April 24 to April 26, 2025 in Sochi.

The Congress sets its goals:

• familiarization of doctors with men's health problems;
• creation of a platform for interaction between doctors to preserve and maintain the active longevity of the male population;
• the introduction of modern technologies for the diagnosis and treatment of diseases affecting men's health in the practice of doctors of various specialties.

The following events were held within the framework of the congress:

• round tables;
• educational schools;
• The Dynasty Award;
• workshops;
• an hour with experts;
• urological brain ring;
• the exhibition exposition.

Representatives of our company made their reports:

• Yakov Mirkin and Aliya Yamilova report on "Does speed matter?!"
• Yakov Mirkin report on the topic "Selection criteria for patients for surgical treatment of premature ejaculation"
• Yasar Basaga (Turkey) report on "Minimally invasive methods of premature ejaculation treatment: botuloxin and selective minimally invasive cryoablation"

The company "Riviera Biotech" presented its products:

• CRYO-S ® Painless Cryosurgical Device
• the "Urolife" line
• the "Prostenol" line
• bioactive complex "For men's reproductive health"